Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 40401-40450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05845905
Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension
NARecruiting
158 participants
Started: May 10, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05862337
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
PHASE3Recruiting
480 participants
Started: May 10, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor67 locations
NCT05617599
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
N/ARecruiting
508 participants
Started: May 10, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor21 locations
NCT05864638
Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study
N/ARecruiting
10,000 participants
Started: May 10, 2023 · Completed: Aug 31, 2028
4 conditions1 sponsor1 location
NCT05756829
Type 1 Diabetes Virtual Self-management Education and Support
NARecruiting
580 participants
Started: May 10, 2023 · Completed: Mar 31, 2027
1 condition1 sponsor7 locations
NCT05786417
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
PHASE4Recruiting
960 participants
Started: May 10, 2023 · Completed: May 30, 2027
2 conditions1 sponsor9 locations
NCT06622954
Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients
NARecruiting
32 participants
Started: May 10, 2023 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06151951
Comparative Effects of Visual and Pressure Biofeedback in Symptomatic Forward Head Posture.
NARecruiting
28 participants
Started: May 10, 2023 · Completed: Jan 10, 2024
1 condition1 sponsor2 locations
NCT05609240
Colo-Pro_2: Bolus-continuous Infusion Cefuroxime Prophylaxis for the Prevention of Infections After Colorectal Surgery
PHASE2Recruiting
180 participants
Started: May 10, 2023 · Completed: May 1, 2025
2 conditions3 sponsors3 locations
NCT05843409
Mindfulness-based Stress Reduction (MBSR) for Reduction of Chronic Pain and Drug Therapie
NARecruiting
200 participants
Started: May 10, 2023 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT05667064
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
N/ARecruiting
300 participants
Started: May 10, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor83 locations
NCT05718791
CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
N/ARecruiting
100 participants
Started: May 10, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT05830877
The Study on the Evaluation of Acupuncture Therapy on Primary Insomnia
NARecruiting
84 participants
Started: May 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06321588
Autoimmune Dementia: Predictors of Neuronal Synaptic Antibodies in Patients With New-ONset Cognitive Impairment
N/ARecruiting
300 participants
Started: May 10, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor3 locations
NCT05471973
CIED Infection Quality Initiative Demonstration Project
NARecruiting
200 participants
Started: May 10, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors3 locations
NCT05710328
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
PHASE2Recruiting
235 participants
Started: May 10, 2023 · Completed: Dec 31, 2029
4 conditions1 sponsor102 locations
NCT05856409
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
N/ARecruiting
20 participants
Started: May 10, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06549270
Biochemical Profiling of Migraine Patients
N/ARecruiting
100 participants
Started: May 10, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT06220812
Different Modalities Interventions Post Supracondylar Humeral Fracture in Pediatrics
NARecruiting
40 participants
Started: May 10, 2023 · Completed: Oct 15, 2024
1 condition1 sponsor1 location
NCT06587971
Intensive Treatment on Periodontitis in Aortic Stenosis
NARecruiting
920 participants
Started: May 10, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT06061757
Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
NARecruiting
52 participants
Started: May 10, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06197919
Effect of Posture and Breathing Exercises in Forward Head Posture
NARecruiting
36 participants
Started: May 10, 2023 · Completed: Jan 10, 2024
1 condition1 sponsor2 locations
NCT05744635
Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients
N/ARecruiting
110 participants
Started: May 10, 2023 · Completed: Jun 1, 2026
1 condition2 sponsors2 locations
NCT06189079
Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
N/ARecruiting
60 participants
Started: May 10, 2023 · Completed: May 10, 2026
1 condition1 sponsor1 location
NCT06181864
Emotional Regulation in Individuals With Autism
NARecruiting
40 participants
Started: May 10, 2023 · Completed: Feb 10, 2025
2 conditions2 sponsors1 location
NCT06416709
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
PHASE1/PHASE2Recruiting
80 participants
Started: May 10, 2023 · Completed: May 10, 2026
1 condition2 sponsors1 location
NCT06629467
Cognitive Behavioral Treatment with Activity Trackers for Smoking Cessation
NARecruiting
128 participants
Started: May 10, 2023 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05295680
Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
PHASE2Recruiting
24 participants
Started: May 10, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06562413
Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments
N/ARecruiting
100 participants
Started: May 10, 2023 · Completed: May 31, 2026
3 conditions2 sponsors1 location
NCT06110039
Comparative Effects of Cervicothoracic Junction Mobilization and Thoracic Manipulation in Subachromial Impinegment Syndrome
NARecruiting
30 participants
Started: May 10, 2023 · Completed: Jan 10, 2024
1 condition1 sponsor1 location
NCT05663502
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
N/ARecruiting
200 participants
Started: May 10, 2023 · Completed: Aug 31, 2035
12 conditions2 sponsors8 locations
NCT05028829
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
PHASE2Recruiting
60 participants
Started: May 10, 2023 · Completed: Mar 1, 2031
2 conditions2 sponsors2 locations
NCT05902819
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
NARecruiting
210 participants
Started: May 10, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05763615
3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project
NARecruiting
20 participants
Started: May 10, 2023 · Completed: May 31, 2026
2 conditions2 sponsors1 location
NCT05702905
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
PHASE4Recruiting
75 participants
Started: May 9, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT05607290
Clinical Course of Alcohol Use Disorder Recovery
NARecruiting
250 participants
Started: May 9, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05462613
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
PHASE2/PHASE3Recruiting
446 participants
Started: May 9, 2023 · Completed: Nov 30, 2030
1 condition1 sponsor16 locations
NCT05901597
Refractive Accuracy of Argos in Conjunction With the Alcon Vision Suite Following Implantation of Presbyopia Correcting IOLs
N/ARecruiting
100 participants
Started: May 9, 2023 · Completed: Dec 15, 2025
1 condition2 sponsors1 location
NCT05729789
Group Written Exposure Therapy for Posttraumatic Stress Disorder
NARecruiting
63 participants
Started: May 9, 2023 · Completed: May 9, 2025
1 condition1 sponsor1 location
NCT05847465
Study of Thermoregulation in Exercise Heat Stroke in the Military Environment
N/ARecruiting
50 participants
Started: May 9, 2023 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05839314
Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
PHASE4Recruiting
480 participants
Started: May 9, 2023 · Completed: Jul 1, 2027
3 conditions3 sponsors1 location
NCT05716100
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
PHASE3Recruiting
360 participants
Started: May 9, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors69 locations
NCT05982834
Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGC
PHASE1/PHASE2Recruiting
43 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05827042
Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion
PHASE3Recruiting
338 participants
Started: May 9, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT05753215
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
PHASE2Recruiting
180 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT06308536
Application of Concentrated Growth Factors in Alveolar Ridge Preservation
NARecruiting
20 participants
Started: May 9, 2023 · Completed: Apr 1, 2025
2 conditions1 sponsor1 location
NCT05789069
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
PHASE1Recruiting
83 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor11 locations
NCT05562557
A Regional Partnership to Improve Outcomes Through Fatherhood Engagement
NARecruiting
240 participants
Started: May 9, 2023 · Completed: Sep 30, 2027
5 conditions2 sponsors1 location
NCT05826535
Study of LYL314 in Aggressive Large B-Cell Lymphoma
PHASE1/PHASE2Recruiting
270 participants
Started: May 9, 2023 · Completed: Jun 30, 2031
4 conditions1 sponsor20 locations
NCT05747625
(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma
PHASE1Recruiting
60 participants
Started: May 9, 2023 · Completed: Mar 1, 2030
3 conditions2 sponsors1 location